Literature DB >> 27210811

Inhibition of human norovirus by a viral polymerase inhibitor in the B cell culture system and in the mouse model.

Abimbola O Kolawole1, Joana Rocha-Pereira2, Michael D Elftman3, Johan Neyts2, Christiane E Wobus4.   

Abstract

The recently developed human norovirus (HuNoV) B cell culture and mouse models hold promise for drug discovery and development but their suitability for antiviral studies has not been assessed. We demonstrate the inhibitory effect of the nucleoside analogue 2'-C-methylcytidine (2CMC) on HuNoV replication in the human B cell BJAB cell line and in Balb/c Rag/gamma chain-deficient (Rag-γc(-/-)) mice. These data suggest the applicability of both models for future study and development of antiviral drugs for the treatment of HuNoV infections.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral; Enteric virus; Human norovirus; Polymerase inhibitor; Positive-sense RNA virus

Mesh:

Substances:

Year:  2016        PMID: 27210811      PMCID: PMC4980194          DOI: 10.1016/j.antiviral.2016.05.011

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  25 in total

1.  Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.

Authors:  Joana Rocha-Pereira; Jana Van Dycke; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 2.  Advances in norovirus biology.

Authors:  Stephanie M Karst; Christiane E Wobus; Ian G Goodfellow; Kim Y Green; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

3.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

Review 4.  Human caliciviruses and pediatric gastroenteritis.

Authors:  Sarbelio Moreno-Espinosa; Tibor Farkas; Xi Jiang
Journal:  Semin Pediatr Infect Dis       Date:  2004-10

5.  Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line.

Authors:  Kyeong-Ok Chang; Stanislav V Sosnovtsev; Gaël Belliot; Adriene D King; Kim Y Green
Journal:  Virology       Date:  2006-07-14       Impact factor: 3.616

6.  Antiviral activity of nucleoside analogues against norovirus.

Authors:  Verónica P Costantini; Tony Whitaker; Leslie Barclay; David Lee; Tamara R McBrayer; Raymond F Schinazi; Jan Vinjé
Journal:  Antivir Ther       Date:  2012-08-14

7.  The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model.

Authors:  Joana Rocha-Pereira; Dirk Jochmans; Yannick Debing; Erik Verbeken; Maria S J Nascimento; Johan Neyts
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 8.  Norovirus gastroenteritis in immunocompromised patients.

Authors:  Karin Bok; Kim Y Green
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

Review 9.  Systematic literature review of role of noroviruses in sporadic gastroenteritis.

Authors:  Manish M Patel; Marc-Alain Widdowson; Roger I Glass; Kenichiro Akazawa; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

10.  World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010.

Authors:  Arie H Havelaar; Martyn D Kirk; Paul R Torgerson; Herman J Gibb; Tine Hald; Robin J Lake; Nicolas Praet; David C Bellinger; Nilanthi R de Silva; Neyla Gargouri; Niko Speybroeck; Amy Cawthorne; Colin Mathers; Claudia Stein; Frederick J Angulo; Brecht Devleesschauwer
Journal:  PLoS Med       Date:  2015-12-03       Impact factor: 11.069

View more
  31 in total

1.  TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.

Authors:  Daniel Enosi Tuipulotu; Natalie E Netzler; Jennifer H Lun; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  Enhanced GII.4 human norovirus infection in gnotobiotic pigs transplanted with a human gut microbiota.

Authors:  Shaohua Lei; Erica L Twitchell; Ashwin K Ramesh; Tammy Bui; Elizabeth Majette; Christine M Tin; Roger Avery; Gustavo Arango-Argoty; Liqing Zhang; Sylvia Becker-Dreps; M Andrea Azcarate-Peril; Xi Jiang; Lijuan Yuan
Journal:  J Gen Virol       Date:  2019-11       Impact factor: 3.891

Review 3.  Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.

Authors:  Eunüs S Ali; Harinda Rajapaksha; Jillian M Carr; Nikolai Petrovsky
Journal:  Antiviral Res       Date:  2016-07-13       Impact factor: 5.970

4.  Birth Cohort Studies: Toward Understanding Protective Immunity to Human Noroviruses.

Authors:  Robert L Atmar; Sasirekha Ramani
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

Review 5.  Recent advances in understanding noroviruses.

Authors:  Eric Bartnicki; Juliana Bragazzi Cunha; Abimbola O Kolawole; Christiane E Wobus
Journal:  F1000Res       Date:  2017-01-26

6.  Human norovirus binding to select bacteria representative of the human gut microbiota.

Authors:  Erin A Almand; Matthew D Moore; Janie Outlaw; Lee-Ann Jaykus
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

7.  In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase.

Authors:  Salvatore Ferla; Natalie E Netzler; Sebastiano Ferla; Sofia Veronese; Daniel Enosi Tuipulotu; Salvatore Guccione; Andrea Brancale; Peter A White; Marcella Bassetto
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

8.  Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro.

Authors:  Mitsutaka Kitano; Myra Hosmillo; Edward Emmott; Jia Lu; Ian Goodfellow
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

9.  Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Identification of active compounds.

Authors:  Jana Van Dycke; Jasper Rymenants; Johan Neyts; Joana Rocha-Pereira
Journal:  Antivir Chem Chemother       Date:  2021 Jan-Dec

Review 10.  Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.

Authors:  Souvik Ghosh; Yashpal Singh Malik; Nobumichi Kobayashi
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.